Shakiba Nazemian

Shakiba Nazemian

Auto-generated profile, based on publicly available information

Shakiba Nazemian

Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2025 in European Journal of Medical Research
Verified
Journal Article
Open access
PDF file
SSSoheil Sadr
Soheil Sadr
AHAshkan Hajjafari
Ashkan Hajjafari
Alireza SazmandAlireza Sazmand
Alireza Sazmand
CSCinzia Santucciu
Cinzia Santucciu
GMGiovanna Masala
Giovanna Masala
HBHassan Borji
Hassan Borji
Parasitic infections remain a serious public health issue globally, requiring prompt and precise diagnosis. Traditional diagnostic techniques, such as microscopic examinations, immunological methods, such as enzyme-linked immunosorbent assay (ELISA), and molecular tests, such as polymerase chain reaction (PCR), are standard tools for parasite identification. However, traditional methods are time-consuming and have less sensitivity and specificity than nanobiosensors. Hence, the current review aims to analyze the nanobiosensors in detecting globally important human parasites, i.e., Plasmodium, Leishmania, Echinococcus, Schistosoma, and Taenia, emphasizing their significance in the early detection and analyzing their future challenges. Nanobiosensors provide efficient, sensitive, and rapid diagnosis of parasites’ antigens or genetic material using nanomaterials, such as nanowires, quantum dots (QDs), metallic nanoparticles, and carbon nanotubes, as well as identification of biomarkers, including excretory–secretory products and microRNAs. Nanobiosensors can utilize diverse nanomaterials such as gold nanoparticles (AuNPs) for the detection of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) in Plasmodium, carbon nanotubes (CNTs) functionalized with anti-EgAgB antibodies for Echinococcus, and QDs labeled with DNA probes for the detection of Leishmania kDNA. Regarding Schistosoma, graphene oxide (GO)-based nanobiosensors with a soluble egg antigen (SEA) binding, and for Taenia, metallic nanobiosensors can detect parasites’ biomarkers even at low concentrations. Challenges for using nanobiosensors in parasitic infection diagnosis include limitations in mass production, biological matrix interference, and the need for standardization. Development of multiplex nanobiosensors using polymer nanofibers or hybrid nanoparticles for simultaneous detection of multiple pathogens, along with integration of lab-on-a-chip technology for point-of-care (PoC) platforms, is an important future prospect that needs to be worked on. In conclusion, considering the rapidly ongoing advancement of nanobiosensors, it is expected that they will aid the detection, treatment, and management of parasitic infections by providing new avenues for early detection, improved treatment, and improved disease management in the future. Graphical Abstract

22 April 2025 in Chemical Engineering Journal
Verified
Journal Article
Closed access
SSSoheil Sadr
Soheil Sadr
SNShakiba Nazemian
Shakiba Nazemian
SDShiva Dianaty
Shiva Dianaty
AHAshkan Hajjafari
Ashkan Hajjafari
BFBita Fazel
Bita Fazel
HBHassan Borji
Hassan Borji

17 April 2025 in Current Research in Parasitology & Vector-Borne Diseases
Verified
Journal Article
Open access
SSSoheil Sadr
Soheil Sadr
ISIraj Sharifi
Iraj Sharifi
SMSolmaz Morovati
Solmaz Morovati
HSHelia Sepahvand
Helia Sepahvand
SNShakiba Nazemian
Shakiba Nazemian
BABaharak Akhtardanesh
Baharak Akhtardanesh
Leishmaniasis, the most neglected tropical disease caused by protozoan parasites of the genus Leishmania, poses a substantial global health concern. The present review provides an in-depth overview of current findings on apoptosis and cell death mechanisms in leishmaniasis, integrating current advancements and key components. It explores the intricate interaction between Leishmania spp. and host cell apoptosis, a crucial basis of disease outcome. Leishmania spp. and host cell death pathways interplay is highly complex and multi-layered, and the current review discusses how Leishmania parasites manipulate host cell apoptotic signal transduction to establish and sustain infection. This includes the subversion of intrinsic and extrinsic apoptotic signaling, the modulation of pro- and anti-apoptotic proteins, and managing host cell death machinery for their survival and pathogenesis. Moreover, the present review explores the emerging evidence of apoptosis in Leishmania parasites. This fascinating phenomenon, while less widely studied, recommends immense therapeutic potential in targeting parasite-persistent mechanisms. Finally, we critically analyze the challenges and future directions in this field, emphasizing the need for a deeper understanding of the merits and mediator molecular mechanisms underlying Leishmania-induced apoptosis and its implications for novel therapeutic strategies against this debilitating disease.